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Object. Endoscopically assisted ventricular catheter placement has been reported to reduce shunt failure in uncontrolled 
series. The authors investigated the efficacy of this procedure in a prospective multicenter randomized trial.
Methods. Children younger than 18 years old who were scheduled for their first ventriculoperitoneal (VP) shunt place­
ment were randomized to undergo endoscopic or nonendoscopic insertion of a ventricular catheter. Eligibility and prima­
ry outcome (shunt failure) were decided in a blinded fashion. An intention-to-treat analysis was performed. The sample 
size offered 80% power to detect a 10 to 15% absolute reduction in the 1-year shunt failure rate.
The authors studied 393 patients from 16 pediatric neurosurgery centers between May 1996 and November 1999. Me­
dian patient age at shunt insertion was 89 days. The baseline characteristics of patients within each group were similar: 
54% of patients treated with endoscopy were male and 55% of patients treated without endoscopy were male; 30% of pa­
tients treated with and 26% of those without endoscopy had myelomeningocele; a differential pressure valve was used in 
51% of patients with and 49% of those treated without endoscopy; a Delta valve was inserted in 38% of patients in each 
group; and a Sigma valve was placed in 9% of patients treated with and 12% of those treated without endoscopy. Median 
surgical time lasted 40 minutes in the group treated with and 35 minutes in the group treated without endoscopy. Ventric­
ular catheters, which during surgery were thought to be situated away from the choroid plexus, were demonstrated to be 
in it on postoperative imaging in 67% of patients who had undergone endoscopic insertion and 61% of those who had 
undergone nonendoscopic shunt placements. The incidence of shunt failure at 1 year was 42% in the endoscopic insertion 
group and 34% in the nonendoscopic group. The time to first shunt failure was not different between the two groups (log 
rank = 2.92, p = 0.09).
Conclusions. Endoscopic insertion of the initial VP shunt in children suffering from hydrocephalus did not reduce the 
incidence of shunt failure.
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H y d r o c e p h a l u s  is a common pediatric disorder6 that 
is usually managed by VP shunt insertion. The fail­
ure rate of VP shunts in children is approximately 
40% at 1 year after insertion.5,9 The most common cause of 
shunt failure is ventricular catheter obstruction14 by the cho­
roid plexus.2 To minimize this problem, surgeons attempt to 
place the ventricular catheter away from the choroid plexus 
(in the frontal horn, above the foramen of Monro, or in the 
occipital horn),14 a task most often achieved using anatom­
ical landmarks.
In the early 1990s, fiberoptic endoscopes became avail­
able for use in shunt placement surgery. They fit in the ven­
tricular catheter lumen and protrude through a slit in the tip 
of the catheter. This allows visualization inside the ventricle 
so that the catheter can be placed away from the choroid
Abbreviations used in this paper: CSF = cerebrospinal fluid; 
CT = computerized tomography; MR = magnetic resonance; VP = 
ventriculoperitoneal.
plexus.19 Evidence from uncontrolled series indicates that 
endoscopic insertion of the ventricular catheter reduces the 
incidence of VP shunt failure. Crone3 reported a 3% annual 
shunt failure rate following endoscopic catheter placement, 
and subsequently, Taha and Crone15 described their experi­
ence with 100 patients. In 68 of these 100 patients, a large 
(4-mm) endoscope in a peel-away sheath was used to iden­
tify the choroid plexus. The scope was removed and the 
ventricular catheter was threaded down the sheath. In the 
remaining 32 patients, a tiny endoscope was passed through 
the lumen of the ventricular catheter for shunt placement. 
Postoperative imaging demonstrated proper catheter place­
ment in 98% of patients. The mean follow up was 2.5 years 
and 13 patients (13%) experienced shunt failure.
Manwaring11 reported his experience with more than 200 
endoscopically guided procedures. The ventricular cathe­
ter placement method was similar to that used by Taha and 
Crone.15 The tip of the ventricular catheter was positioned 
in the frontal horn, at the foramen of Monro, or through the
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foramen into the third ventricle. Postoperative neuroimag­
ing visualized tip positioning at the selected site in 90% of 
cases. Forty-nine percent of endoscopic shunt insertions 
and 67% of nonendoscopic ones required revision in the 
1st year.
A series of 37 patients who had undergone shunt place­
ment surgery with endoscopy were compared with 40 ran­
domly selected patients who had undergone surgery with­
out endoscopy.17 Frameless stereotaxy was used in 12 of the 
endoscopically assisted cases and in none of the standard 
shunt placement cases. The first postoperative image was 
assessed by two independent, nonblinded examiners. The 
position of the catheter tip was optimal in 34 of 42 endo­
scopic procedures compared with 17 of 40 standard inser­
tion procedures. Long-term shunt patency was not reported 
in this study.
There are potential risks associated with endoscopic 
shunt placement. Taha and Crone15 found that the operative 
time was slightly longer when using the endoscope. Man- 
waring11 attributed a shunt infection to the use of the endo­
scope. Bleeding, injury to the ventricular wall, hypothalam­
ic dysfunction, eye movement abnormalities, seizures, fluid 
leak, and cardiac arrest have all been reported as complica­
tions of endoscopic neurosurgery at an overall rate of 7 to 
8%.716 Many of these factors are also potential complica­
tions of endoscopic shunt placement. In addition, the endo­
scopic equipment is expensive and disposable.
Based on the suggestive evidence from uncontrolled se­
ries, we conducted a randomized clinical trial. Our specific 
objective was to measure the time to first shunt failure after 
its placement with the aid of an endoscope and to compare 
it with the time to first shunt failure after its insertion with­
out an endoscope, in children with hydrocephalus.
Clinical M aterial and Methods
Patient Characteristics
The study population consisted of 55% male patients 
with a median age of 89 days. The most common causes of 
hydrocephalus were myelomeningocele (108 [27%] of 393) 
and intraventricular hemorrhage (82 [21%] of 393). Thir­
teen patients had persistent hydrocephalus after undergoing 
a third ventriculostomy. Baseline characteristics of patients 
in the study groups were similar (Table 1).
Study Entry and Exclusion Criteria
Patients eligible to enter the study were younger than 18 
years of age, had clinically suspected hydrocephalus, were 
scheduled to undergo a VP shunt insertion procedure, and 
had ventriculomegaly based on neuroimaging (ultrasonog­
raphy, CT scanning, or MR imaging studies). Those at risk 
of an immediate complication or those slated to undergo 
shunt placement for a condition other than hydrocephalus 
were excluded. The specific exclusion criteria were: 1) the 
presence of a previously inserted indwelling shunt; 2) an 
active shunt, CSF, or abdominal infection; 3) spread of tu­
mor into the subarachnoid space documented on enhanced 
CT or MR imaging of the head or spine; 4) loculation(s) 
within the ventricular system; 5) either a Dandy-Walker 
malformation or an arachnoid cyst as the cause of hydro­
cephalus; 6) hydranencephaly; 7) severe prematurity with
TABLE 1
Baseline characteristics o f 393 patients who underwent 






median age (days) 84 110
sex (% male) 54 55
gestational age (wks) 38 38
birth weight (g) 2920 2960
cause of hydrocephalus
myelomeningocele 57 51
intraventricular hemorrhage 46 36
aqueductal stenosis 10 19
tumor 9 10
CSF infection 8 8
head injury 5 8
two or more causes 9 8
other 11 16
unknown 39 43
median head circumference (cm) 40 40
previous third ventriculostomy 6 8
previous subcutaneous reservoir 8 11
previous external ventricular drain 20 15
previous subgaleal shunt 7 2
baseline imaging results
transependymal edema 21 22
intraventricular blood 19 21
thin fragile skin through which a shunt might erode; 8) oth­
er systemic disorders that would preclude the insertion of 
a VP shunt; or 9) other difficulties that would preclude a 
1-year follow up. Pediatric neurosurgeons who had per­
formed five or more endoscopic ventricular catheter inser­
tions were eligible for participation in the study.
Treatment Protocol
The shunt insertion procedure was not dictated by our 
protocol except for the following items: 1) the shunt was in 
an adequate position when CSF was flowing from the dis­
tal end; 2) Orbis Sigma valves were inserted through a hole 
in the skull and dura mater, which was just large enough to 
permit the passage of the ventricular catheter; and 3) if us­
ing Delta valves, a subgaleal pocket was created in order to 
avoid compression by the scalp. Surgeons were allowed to 
choose the specific features of the shunt, but antisiphon de­
vices and other flow-control devices were not allowed.
The endoscope was passed down the lumen of the ven­
tricular catheter. Use of an endoscope outside the ventricu­
lar catheter or through a separate entry site was not permit­
ted. The goal of endoscopic insertion was the placement of 
the ventricular catheter tip away from the choroid plexus.
Perioperative care of the patients was conducted accord­
ing to each surgeon’s usual practice. Patients were required 
to undergo surgery within 1 month of being found eligible 
for the procedure.
Patient Outcome
The primary outcome in this study was shunt failure as 
previously defined in the Shunt Design Trial.4 There were 
four categories of shunt failure (obstruction, overdrainage, 
loculation, and infection), and the occurrence of any of 
them was accepted as the primary end point.
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Fig. 1. Schematic outline of study design.
Shunt Obstruction. There were four different definitions 
of shunt obstruction. If a patient demonstrated the requisite 
features of any of these four definitions, shunt obstruction 
was said to have occurred. First, shunt obstruction occurred 
if a patient had at least one of the following symptoms or 
signs and at least one positive result on an ancillary test. 
Symptoms included headache, nausea, vomiting, decreased 
level of consciousness, irritability, decreased school per­
formance, or the loss of developmental milestones. Signs 
included papilledema, bulging fontanelle, nuchal rigidity, 
sixth cranial nerve paresis, loss of upward gaze, new sei­
zures (or increased seizure frequency), increasing head 
circumference, fluid tracking along the shunt tubing, um- 
bilication of the shunt reservoir, or inability to depress the 
shunt reservoir. Note that fluid accumulation around the 
burr hole site in the early weeks following surgery was not 
considered to be indicative of shunt failure unless it was 
extreme and progressive or resulted in the leakage of CSF 
through the wound. Small fluid collections are common and 
normally resolve spontaneously.
A positive result on an ancillary test was described as fol­
lows: 1) results of CT scanning, ultrasonography, or MR 
imaging studies demonstrating enlarged ventricles com­
pared with their appearance on 3-month studies or ven­
tricles that failed to decrease in size compared with their 
appearance on preoperative studies (normalization of ven­
tricle size is not a mandatory criterion for shunt function);
2) disruption or migration of the shunt system exhibited on 
plain radiographs; 3) radionucleotide or iodinated contrast 
study displaying shunt obstruction; 4) intracranial pressure 
monitoring indicating persistent elevation of pressure with 
or without plateau waves; or 5) shunt tap in which fluid can­
not be aspirated or high pressure is recorded or symptoms 
and/or signs of shunt obstruction are relieved.
Second, shunt obstruction occurred if there were no 
symptoms or signs of obstruction but the ventricles were 
increased in size and there was no clinical or radiograph­
ic evidence that atrophy was the cause of the ventricular 
enlargement. Third, a CSF leak that did not resolve and re­
quired a shunt revision was considered to be a shunt ob­
struction. Last, in the rare event of an emergency shunt 
revision with no ancillary tests or a revision prior to the 
3-month follow-up scan, obstruction was judged to be pres­
ent or absent by using clinical information, results of imag­
ing studies (if available), and the operative findings.
Shunt Overdrainage. Shunt overdrainage occurred in the 
presence of either large subdural fluid collections associat­
ed with brain compression or symptoms and signs other­
wise indicative of shunt obstruction, or slit ventricle syn­
drome. The latter was characterized by smaller than normal 
ventricles associated with postural headache, chronic head­
ache, intermittent headache of an incapacitating nature, and 
documentation of one of the following factors: transient en­
largement of the ventricles as demonstrated on imaging, 
extreme negative pressure (on intracranial pressure moni­
toring or a shunt tap) with associated headache while the 
patient was in an upright position, or sustained elevations of 
pressure higher than normal and associated with headache.
Loculated Compartments. The presence of a loculated 
portion of a ventricular system, which is enlarged more than 
normal, compressing surrounding brain, and which requires 
repeated operation, was considered to be evidence of shunt 
malfunction and accepted as an end point of the study.
Shunt Infection. Shunt infection was indicated by the pres­
ence of purulent discharge through the wound or erosion of 
the shunt material through the skin. Further, it was char­
acterized by the presence of one of the following symp­
toms or signs plus positive results of at least one of the fol­
lowing ancillary tests. Symptoms and signs consisted of 
those indicative of shunt obstruction, fever, meningismus, 
wound erythema, abdominal pain and/or distention, abdom­
inal mass, or peritonitis. Ancillary tests performed included 
the culture or identification of organisms on Gram staining 
of CSF obtained from shunt lumen or abdominal fluid col­
lection, if present, which was withdrawn under sterile con­
ditions or from purulent material around the shunt. The 
growth of organisms from the entire shunt material in broth 
culture in the absence of other positive culture results was 
not considered to be indicative of an infection.
The secondary outcomes considered were subtype of 
shunt failure, surgical complications, patient survival, cause 
of death, and ventricular catheter position. Follow up was 
scheduled to be performed 4 to 12 weeks after shunt surgery 
and annually thereafter.
Sample Size
The overall 1-year shunt failure rate in the control group 
from the literature was 30 to 40%.1,4,5,13,14 The clinically im­
portant difference was chosen as a decrease in the 1-year 
shunt failure rate to 20%. Using Cochrane and colleagues’1 
cost analysis model of shunt failure, we calculated that such 
a reduction in shunt failure would result in a savings of 
more than $1.5 million over 3 years at the study centers. 
The alpha value was chosen to be 0.05 (two-tailed test), and 
the power was 80%. A 2-year accrual period with a mini­
mum 1-year follow up was planned. Based on these param­
eters, a sample size of 350 patients10 would have an 80% 
power to detect a reduction in the incidence of shunt failure 
at 1 year from 0.5 to 0.35, from 0.4 to 0.25, from 0.3 to 0.2, 
or from 0.2 to 0.1.
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Survival Analysis
The primary analysis included all patients in their orig­
inally assigned randomization groups (that is, an intention- 
to-treat analysis).12 Patients who were subsequently judged 
to be ineligible were left in the primary analysis. Data in 
patients who did not meet the end point were censored at 
the last follow up. Data in patients who underwent other in­
tracranial surgery, which, on blinded review, was thought 
potentially to affect shunt function, were excluded at the 
time of that surgery. In addition, data in patients were cen­
sored at the time of death if the cause of death was not shunt 
related. Deaths due to shunt failure were considered as 
an end point in the appropriate category. Time to shunt fail­
ure or data censoring was used to generate Kaplan-Meier 
curves for patients in the endoscopically treated group and 
those who underwent standard insertion procedures. These 
results were compared using a log-rank test. Statistical sig­
nificance occurred at probability values less than 0.05.
Patient Group Assignment
Patients were individually randomized to treatment 
groups. Randomization was stratified by surgeon and shunt 
valve (Fig. 1). A permuted block randomization scheme 
was generated from a random number generator. An Access 
software program was designed to store the randomization 
scheme and to display sequentially the treatment assign­
ments after patient demographic data were entered. The 
program was tested and installed on a computer in the op­
erating room at each center. Patient consent was obtained 
prior to surgery and randomization was performed in the 
operating room by participating surgeons.
Blinding Method
Blinding of surgeons to the treatment assignment was not 
possible. An adjudication process for eligibility and pri­
mary outcome similar to that used in the Shunt Design Tri- 
al8 was followed. All case report forms, clinical notes, and 
imaging studies were sent to the data coordinating center, 
masked, and reviewed. The blinded review process was 
used to determine whether a patient met the entry and out­
come criteria for the study. The results of the blinded review 
process were used as the primary outcome for the trial.
Results
Patient accrual began in May 1996 and closed in Novem­
ber 1999. Minimum follow up took place 1 year postsur­
gery. Three hundred ninety-three patients were randomized: 
194 to endoscopic shunt insertion and 199 to standard shunt 
insertion. Seventeen of the 393 patients were subsequently 
ruled to be ineligible for the study during the blinded adju­
dication process. Nine of the 17 patients had been random­
ized to endoscopic insertion, eight to standard insertion. 
The reasons for ineligibility were no hydrocephalus (four 
patients), ventricular catheter placement in an old external 
ventricular drain track (four patients), shunt insertion into 
an empty hemicranium after hemispherectomy (three pa­
tients), spread of tumor into the subarachnoid space (two 
patients), arachnoid cyst (one patient), loculated ventricles 
(one patient), Dandy-Walker malformation (one patient), 
and previously inserted shunt (one patient).
0 1 2 3 4 5
Time (years)
Fig. 2. Kaplan-Meier curves showing the shunt failure rate in 
patients in the group treated with endoscopy (solid line) and those 
treated without endoscopy (dotted line). Log-rank test = 2.92, 
p = 0.09.
Surgical Procedure
Surgeons usually chose to use differential pressure (stan­
dard) valves (195 [50%] of 393) or Delta valves (150 [38%] 
of 393). The administration of perioperative antibiotics 
(339 [86%] of 393) and the removal of hair (268 [68%] of 
393) were common practices. The median time for surgery 
was 35 minutes.
Bleeding was observed during the endoscopic procedure 
in 18 patients. The source of bleeding reportedly originat­
ed from an unknown site (six patients), the ventricle wall or 
ependyma (five patients), the choroid plexus (three pa­
tients), an old blood clot (three patients), or the occipital 
horn (one patient). in three of these 18 cases, bleeding in­
terfered with adequate visualization through the endoscope 
and the shunt was placed without endoscopic assistance. in 
one of 18 patients, the fluid was very dark from a previ­
ous hemorrhage. The surgeon was concerned that the shunt 
would become blocked because of the consistency of the 
fluid, and thus no shunt was inserted. Visualization was 
poor in one other patient, who had hydrocephalus caused by 
meningitis; the murky yellow fluid interfered with visual­
ization and the shunt was placed without endoscopic assis­
tance.
Shunt Failure
The overall incidence of shunt failure was 0.38 at 1 year 
postsurgery and 0.47 at 2 years postsurgery. There was 
no significant difference in the time to shunt failure in 
comparing patients in the endoscopic and nonendoscopic 
groups (log rank = 2.92, p = 0.09; Fig. 2). The incidence of 
shunt failure at 1 year was 0.42 in patients in the endoscop­
ic group and 0.34 in those in the nonendoscopic group (Ta­
ble 2). Time to shunt failure (Kaplan-Meier curves) was not 
appreciably different when the 17 ineligible patients were 
excluded from analysis, when all deaths were counted as 
primary end point events, or when shunt revision was used 
as the end point (rather than the blindly judged end point).
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Surgery details in 393 patients who underwent placement 







type of shunt inserted
standard 98 97
Delta 74 76
Orbis Sigma 21 26








procedures used to assist ventricular 
catheter placement
ultrasonography 16 32
x-ray film 0 2
stereotaxis 0 0
ventricular catheter placed on first 159 166
attempt 
abdominal entry technique
direct observation 107 113
trocar 66 79
additional procedures 28 23
median surgical time (mins) 40 35
Obstruction was the most common type of shunt failure, 
occurring in 106 (27%) of 393 patients (Fig. 3), that is, in 
66 (34%) of 194 cases treated with endoscopy and in 40 
(20%) of 199 cases treated without endoscopy (Table 3). 
The most common location for obstruction was the ventric­
ular catheter in both groups. The incidence of infection was 
44 (11%) of 393.
Patient Complications 




Shunt Failure (194 patients) (199 patients)
overall incidence (95% confidence interval)
1 yr 0.42 (0.35-0.49) 0.34 (0.27-0.41)
2 yrs 0.51 (0.43-0.59) 0.42 (0.34-0.50)
3 yrs 0.65 (0.55-0.75) 0.55 (0.40-0.70)
type (no. of patients [%])
obstruction* 66 (34) 40 (20)
overdrainage 7 (4) 7 (4)
loculation 3 (2) 6 (3)
infection 20 (10) 24 (12)
obstruction of
ventricular catheter* 33 (17) 22 (11)
Fig. 3. Schematic diagram demonstrating outcomes in 393 ran­
domized patients.
* “Obstruction” refers to shunt failure due to obstruction as defined in the 
text. “Obstruction of ventricular catheter” refers only to obstruction due to 
ventricular catheter occlusion.
curred in patients in the endoscopically treated group and
11 in those in the standard insertion group (Table 4). Two 
patients in the group treated with endoscopy experienced 
intracranial hemorrhage. in one of these patients, there was 
no associated clinical manifestation at the time of dis­
charge; in the other child, seizures and bilateral posterior 
temporal hemorrhages occurred at regions remote from the 
surgical site, but their causes remained unclear. An infant in 
the endoscopically treated group, who had had massive hy­
drocephalus and cardiac anomalies, died immediately after 
shunt insertion and myelomeningocele closure. At the time 
of death the case was reviewed by a blinded adjudicator, 
who thought that the death was not due to the treatment 
group assignment.
Catheter Position
When the surgeon placed the ventricular catheter, he or 
she recorded the location of the catheter tip. This position 
was compared with that demonstrated on the first postoper­
ative brain image obtained in 137 patients treated with en­
doscopy and 149 patients treated without endoscopy. If the 
first postoperative image was an MR image or an ultra­
sonography scan, the position of the catheter tip could not 
always be determined. Among 130 of 137 patients in the 
endoscopically treated group, the surgeon thought that the 
ventricular catheter tip was situated away from the choroid 
plexus (in the frontal horn, above the foramen of Monro, or 
in the occipital horn) at the time of surgery. On the first 
postoperative image, it was away from the choroid plexus 
in 87 (67%) of 130 patients. Among 140 of 149 patients 
treated without endoscopy, the surgeon thought that the 
catheter tip was located away from the choroid plexus at the 
time of surgery. On the first postoperative image, it was 
away from the choroid plexus in 86 (61%) of 140 patients.
The time to shunt failure based on catheter position as 
demonstrated on the first postoperative scan is depicted in 
Fig. 4.
Discussion
Ventricular catheter placement by using endoscopic pro­
cedures appeared very promising based on results of uncon­
trolled series in the literature and prompted our undertak-
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TABLE 4
Complications noted prior to hospital discharge in 29 patients
Complication Endoscope No Endoscope
intracranial hemorrhage 2 0
new or worsened neurological deficit 0 0
wound dehiscence 1 3
postop subcutaneous fluid 7 1
transient CSF leak 2 0
seizures 3 2
non-shunt infection 0 2
persistent emesis 1 1
pneumocele 1 0
bruising along shunt 0 2
death 1 0
total 18 11
ing of this randomized trial. Data from our study, however, 
showed no advantage to endoscopic shunt insertion. Shunt 
failure rates were not significantly different; the incidence 
of shunt failure at 1 year was 0.42 in patients in the group 
treated with endoscopy and 0.34 in those treated without 
endoscopy. The theoretical basis for a reduced shunt fail­
ure rate in devices placed with the aid of an endoscope was 
decreased obstruction of the ventricular catheter; however, 
this was not observed. Early complications were not re­
duced in patients in the endoscopic insertion group and the 
median duration of surgery was slightly longer with the en­
doscope.
There are a number of differences between this trial and 
the studies previously reported in the literature. Our method 
of shunt insertion was restricted to the use of small endo­
scopes that fit in the lumen of the ventricular catheter. These 
scopes were chosen because they were in common use and 
were thought to be an improvement over the larger ones. 
They did not create a large track in the brain, which might 
leak CSF, and the catheter tip could be placed in the same 
position as the tip of the endoscope.
In the studies by Crone3 and Manwaring,11 the majority 
of endoscopic insertions were performed using a larger en­
doscope and a peel-away sheath to guide ventricular cath­
eter placement. In the study by Theodosopoulos and col- 
leagues,17 endoscopy was supplemented with stereotactic 
guidance, shunt revisions were included, and most of their 
patients were adults. In our trial we assessed first shunt in­
sertions in children only.
The current study is more rigorous than those published 
in the past in terms of specific entry and outcome criteria, 
randomization, adequate power, and blind adjudication of 
outcome. In all previous studies, there was potential observ­
er bias because outcome was assessed by the treating sur­
geon. The only study with a control group17 did not include 
clinical follow up and its researchers focused specifically 
on the position of the catheter.
Data from previous research has supported the idea that 
ventricular catheter position affects the incidence of shunt 
failure.18 The results of a secondary analysis of catheter 
position in our trial indicate that shunt failure is less com­
mon if the ventricular catheter is situated away from the 
choroid plexus, as demonstrated on postoperative imaging. 
The goal of placing catheters away from the choroid plexus 
may still be reasonable, but the problem is how to accom­
plish this goal. Despite the surgeons’ belief that a catheter
0 .0 ,  _____ . ,
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Fig. 4. Graph demonstrating the position of the ventricular cath­
eter tip away from (dotted line) the choroid plexus or in proximity 
to it (solid line) at follow up.
had been placed away from the choroid plexus at the time 
of its insertion (in both groups), it was found to be in this 
position only approximately two thirds of the time on the 
postoperative image, and the endoscope did not appear to 
help (67% of endoscopic insertions and 61% of standard in­
sertions were located away from the choroid plexus on the 
postoperative scan).
There are a number of potential reasons for this discrep­
ancy. It is possible that the surgeons mistook the location of 
the catheter tip. Visualization was suboptimal when there 
was blood or other debris in the ventricle. In addition, with 
large ventricles, the small endoscopes may not have provid­
ed enough light for the surgeons to see well.
Alternatively, the ventricular catheter tip may have 
moved after its placement for a number of reasons. The en­
doscope acts as a stylette during placement. If the original 
trajectory of catheter insertion extends toward the choroid 
plexus, the surgeon may redirect the catheter anteriorly, 
toward the frontal horn. It is possible that this could result 
in distortion of the cerebral mantle, and when the scope is 
removed the brain would return to its normal position, per­
haps pulling the catheter back into the choroid plexus. In 
addition, when the ventricle becomes smaller, the position 
of the catheter relative to the choroid plexus may change. 
Many ventricular catheters are designed as straight tubes. 
When inserted they are bent at the insertion site at a 90° 
angle. The elasticity in the tubing tends to straighten the 
tube after placement, resulting in movement of the tip in the 
ventricle. Finally, the entire shunt system occasionally mi­
grates in a caudal direction after its insertion. Any of these 
circumstances may result in catheter tip movement and 
obstruction despite initial placement in an optimal position. 
Future researchers should address optimal catheter po­
sitioning procedures, changes in ventricle size and shape 
after shunt placement, and changes in catheter position 
over time.
Conclusions
Data from the previous literature generated interest in en­
doscopic ventricular catheter placement, but results of this
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trial demonstrated no benefit in the endoscopic insertion 
group and the procedure cannot be recommended.
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